Supriya Lifesci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
901.75
-15.15 (-1.65%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 10.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Supriya Lifesci.
SPARC
Akums Drugs
Sudeep Pharma
Strides Pharma
Shilpa Medicare
Sanofi India
Corona Remedies
P & G Health Ltd
FDC
Blue Jet Health

Why is Supriya Lifescience Ltd ?

1
High Management Efficiency with a high ROE of 17.69%
2
The company is Net-Debt Free
3
With a growth in Net Sales of 3.31%, the company declared Very Positive results in Mar 26
  • NET SALES(Q) At Rs 276.53 cr has Grown at 50.4% (vs previous 4Q average)
  • PBDIT(Q) Highest at Rs 97.62 cr.
  • PBT LESS OI(Q) Highest at Rs 88.65 cr.
4
Increasing Participation by Institutional Investors
  • Institutional investors have increased their stake by 0.65% over the previous quarter and collectively hold 10.86% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Consistent Returns over the last 3 years
  • Along with generating 26.41% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Supriya Lifesci. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Supriya Lifesci. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
26.41%
0.62
42.61%
Sensex
-7.92%
-0.61
13.09%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
7.45%
EBIT to Interest (avg)
88.37
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.70
Tax Ratio
23.90%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
10.86%
ROCE (avg)
27.98%
ROE (avg)
17.69%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
33
Price to Book Value
6.06
EV to EBIT
27.05
EV to EBITDA
24.43
EV to Capital Employed
6.39
EV to Sales
8.68
PEG Ratio
3.03
Dividend Yield
0.11%
ROCE (Latest)
23.63%
ROE (Latest)
17.49%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company
NET SALES(Q)

At Rs 276.53 cr has Grown at 50.4% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 97.62 cr.

PBT LESS OI(Q)

Highest at Rs 88.65 cr.

PAT(Q)

Highest at Rs 74.23 cr.

EPS(Q)

Highest at Rs 9.22

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Supriya Lifesci.

Net Sales - Quarterly
At Rs 276.53 cr has Grown at 50.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 183.86 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 88.65 cr has Grown at 50.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 59.05 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 74.23 cr has Grown at 60.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 46.41 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 276.53 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 97.62 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 88.65 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 74.23 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 9.22
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Supriya Lifesci.

Non Operating Income - Quarterly
Highest at Rs 3.48 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income